Loss of speech and functional impairment in Alzheimer’s disease-related primary progressive aphasia: predictive factors of decline
Mazzeo, Salvatore, Polito, Cristina,Â
Lassi, Michael, Bagnoli, Silvia, Mattei, Marta, Padiglioni, Sonia, Berti, Valentina, Lombardi, Gemma, Giacomucci, Giulia, De Cristofaro, Maria Teresa, Passeri, Alessandro, Ferrari, Camilla, Nacmias, Benedetta, Mazzoni, Alberto, Sorbi, Sandro, and Bessi, Valentina
Neurobiology of Aging Sep 2022
We aimed to identify features associated with different disease trajectories in Alzheimer’s disease (AD)-related primary progressive aphasia (PPA). We considered 23 patients diagnosed with AD-related PPA. All patients underwent neuropsychological evaluation, 18F-Fluorodeoxyglucose-PET brain scan, CSF biomarkers measurement and APOE genotype analysis at baseline and underwent neurological follow-up for a mean time of 3 years. Patients who progressed to total loss of speech (TLoS+) had greater impairment in writing and higher t-tau concentration as compared to TLoS– patients. Patients who progressed to loss of functional autonomy (LoFA+) had greater impairment in single-word comprehension as compared to patients who maintained autonomy in self-care. Furthermore, 18F-FDG-PET SPM analyses revealed different brain metabolic patterns between TLoS+ and TLoS– and between LoFA+ and LoFA–. In conclusion, linguistic profile, CSF t-tau and brain metabolic pattern might be useful tools to predict progression to total loss of speech and loss of functional autonomy in AD-related PPA patients.